Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Clin Cancer Res. 2015 Feb 27;21(11):2624–2634. doi: 10.1158/1078-0432.CCR-14-2667

Figure 1. Sun exposed sites most frequently harbor BRAFi-cSCC.

Figure 1

Distribution and histopathology of all adverse cutaneous squamous cell carcinoma (cSCC) lesions from male (blue, left) and female (rose, right) patients with advanced melanoma treated with BRAF-inhibition (BRAFi). Conventional-cSCC (circles), well-differentiated keratoacanthomatous–type SCC (squares) and conv.-cSCC or cSCC-KA with wart-like features (cSCC-WF, stars).